The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 28, 2023

Filed:

Apr. 14, 2023
Applicant:

Eli Lilly and Company, Indianapolis, IN (US);

Inventors:

Aktham Aburub, Carmel, IN (US);

David Andrew Coates, New Palestine, IN (US);

Scott Alan Frank, Indianapolis, IN (US);

Mark Steven Kerr, Indianapolis, IN (US);

Roger Ryan Rothhaar, Reelsville, IN (US);

Radhe Krishan Vaid, Carmel, IN (US);

Assignee:
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 401/06 (2006.01); A61K 9/20 (2006.01); C07C 51/41 (2006.01);
U.S. Cl.
CPC ...
C07D 401/06 (2013.01); A61K 9/2095 (2013.01); C07C 51/412 (2013.01); C07B 2200/13 (2013.01);
Abstract

The embodiments of present invention provide processes and an intermediate for the large-scale preparation of 2,4,6-trifluoro-N-[6-(1-methylpiperidine-4-carbonyl)-2-pyridyl]benzamide hemisuccinate, and formulations and product forms, such as tablets, made by these processes. Additionally, embodiments of the present invention provide tablets including 25 mg, 50 mg, 100 mg, or 200 mg free base equivalent of 2,4,6-trifluoro-N-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide hemisuccinate.


Find Patent Forward Citations

Loading…